Clinical Trial Update: Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating an amlodipine/atorvastatin combination to reduce health risks from hypertension and hyperlipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• Amlodipine/atorvastatin combination
• atorvastatin (atorvastatin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Hypertension, Hyperlipidemia | Phase 3 | Status: COMPLETED